Question 1

Do I still need governance if my AI scribe vendor is VOR-approved?

Accepted Answer

Yes. The Vendor of Record process confirms the vendor built a responsible product. It does not confirm your clinic is ready to use it responsibly. Your Privacy Impact Assessment, consent workflows, staff training, breach response plan, and ongoing monitoring are all custodian obligations under PHIPA. VOR approval does not transfer or eliminate any of them.

Question 2

What is a Privacy Impact Assessment and does my clinic need one?

Accepted Answer

A PIA evaluates how your clinic collects, uses, stores, and shares personal health information through a specific tool or process. The IPC's January 2026 guidance makes clear that clinics deploying AI scribes should complete a PIA before implementation. It is the foundational document that demonstrates your organization has assessed and addressed privacy risk.

Question 3

What happens if the IPC investigates and we have no governance framework?

Accepted Answer

The IPC can investigate based on a patient complaint, a breach report, or its own initiative. Without documented governance (policies, PIAs, training records, consent processes), your organization has no evidence of due diligence. That is the difference between "we had controls and something still went wrong" and "we had nothing in place." The second outcome carries significantly more regulatory and reputational risk.

Question 4

What if staff are already using AI tools without a formal policy?

Accepted Answer

This is more common than most organizations realize. The first step is not punishment; it is visibility. You need a complete inventory of what AI tools are in use, how patient data flows through them, and where governance gaps exist. From there, you build policy around reality rather than assumptions. Ignoring it does not reduce your liability. It increases it.

Question 5

Can patients refuse AI scribe use during their appointment?

Accepted Answer

Yes, and your clinic must have a documented process for handling that refusal. Consent accommodation is standard clinical practice. The workflow needs to be clear to front desk staff, clinicians, and the patient: what happens when someone opts out, how is it recorded, and how does the appointment proceed without the AI tool. This should be in place before the scribe goes live.

Question 6

How long does it take to implement a governance framework?

Accepted Answer

It depends on your organization's size and complexity, but a focused engagement typically takes 8 to 10 weeks for a full governance build: PIA, policies, consent workflows, training framework, and monitoring plan. A targeted AI scribe package can be completed faster. The longer you wait, the longer your organization operates with unmanaged risk.

Question 7

Do healthcare AI vendors need to meet PHIPA requirements?

Accepted Answer

Indirectly, yes. Clinics are the custodians under PHIPA, but they will not adopt tools from vendors who cannot demonstrate strong privacy controls, secure data handling, and transparency in how their systems work. Weak vendor posture creates procurement friction, slows adoption, and quietly kills deals.

Question 8

Why do deals stall even after our product is approved?

Accepted Answer

Because approval does not resolve the clinic's internal questions. Liability concerns, consent workflow gaps, staff readiness, and leadership uncertainty about risk exposure all sit on the custodian side. If the clinic cannot answer "what happens if something goes wrong?" with confidence, adoption stalls regardless of how strong your product is. Vendors who help clinics answer that question close faster.

Question 9

What is a PIA or TRA from a vendor's perspective?

Accepted Answer

These assessments demonstrate procurement readiness. A PIA shows you have evaluated privacy risk in your product's data handling. A TRA shows you have identified and addressed security threats. Together, they reduce due diligence friction and move you from "interesting tool" to "safe to deploy" in the eyes of institutional buyers and procurement teams.

Question 10

Can we rely on OntarioMD or VOR approval alone?

Accepted Answer

No. OntarioMD approval and VOR listing support adoption, but neither eliminates clinic-level compliance requirements, operational risk, or custodian liability. Vendors who treat VOR as the finish line lose deals to vendors who understand there is an implementation gap and help clinics close it.

Question 11

What is the biggest hidden risk for AI vendors in healthcare?

Accepted Answer

Clinic misuse. A compliant product becomes a liability when it is deployed without consent workflows, used without governance, or misunderstood by clinical staff. When an incident happens in an environment you do not control, your brand is still associated with the failure. Supporting clinic-level governance protects your product's reputation as much as it protects the clinic.

Question 12

Do vendors benefit from working with clinic-level governance consultants?

Accepted Answer

Yes. It reduces friction in your sales cycle, strengthens your credibility with institutional buyers, and helps clinics adopt safely. Vendors that solve beyond the product become long-term partners, not interchangeable tools. The governance layer is what separates vendors who get renewed from vendors who get replaced.

Healthcare & Health Technology

What we see most often

How we help

Relevant services

Other industries

Healthcare AI Governance FAQs

Still deciding where to start?

Ready to move AI from conversation to execution?